Interleukin ‐22 and intestinal homeostasis: Protective or destructive?
This article tries to discuss the latest knowledge on this issu e and clarify the potential of IL‐22 to be used in the future therapeutic approaches of intestinal disorders including inflammatory bowel diseases and colon cancer.
Source: IUBMB Life - Category: Research Authors: Mojtaba Shohan,
Razieh Dehghani,
Ali Khodadadi,
Sajad Dehnavi,
Reza Ahmadi,
Nazanin Joudaki,
Sheyda Houshmandfar,
Marziye Shamshiri,
Samira Shojapourian,
Nader Bagheri Tags: CRITICAL REVIEW Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Dermatology | Epithelial Cancer | Gastroenterology | Inflammatory Bowel Disease | Research